Allergy Therapeutics PLC | Cash Flow
Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
529.00
1,084.00
654.00
12,064.00
1,970.00
6,896
Depreciation, Depletion & Amortization
1,342.00
1,287.00
1,293.00
1,666.00
1,936.00
2,020
Other Funds
1,231.00
280.00
84.00
9.00
1,908.00
911
Funds from Operations
3,102.00
2,091.00
1,863.00
10,389.00
1,942.00
3,965
Changes in Working Capital
651.00
153.00
207.00
1,450.00
2,161.00
211
Net Operating Cash Flow
2,451.00
2,244.00
2,070.00
11,839.00
219.00
3,754
Capital Expenditures
821.00
920.00
1,104.00
1,232.00
1,726.00
Sale of Fixed Assets & Businesses
-
-
1,301.00
-
-
Purchase/Sale of Investments
355.00
281.00
275.00
260.00
258.00
Net Investing Cash Flow
1,176.00
1,201.00
2,731.00
1,492.00
1,984.00
Issuance/Reduction of Debt, Net
-
-
-
1,572.00
221.00
Net Financing Cash Flow
148.00
-
20,079.00
12,539.00
188.00
Net Change in Cash
1,473.00
965.00
19,170.00
2,207.00
1,284.00
Free Cash Flow
1,787.00
1,346.00
979.00
13,071.00
1,281.00
Net Assets from Acquisitions
-
-
2,653.00
-
-
Change in Capital Stock
148.00
-
20,079.00
10,967.00
33.00
Exchange Rate Effect
50.00
78.00
248.00
2,999.00
669.00
About Allergy Therapeutics
View Profile
